Litcius/Paper detail

Comparing the prophylactic effects of oral gabapentin, pregabalin, and celecoxib on postoperative pain management in orthopedic surgery of the lower extremity: A double-blind randomized controlled trial

Dorna Kheirabadi, MohammadReza Safavi, Marzieh Taghvaei, Mohammadreza Habibzadeh, Azim Honarmand

2020Journal of Research in Medical Sciences21 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Lower extremity pain after orthopedic surgery is so frequent that has led to many treatment modalities. This study aims to compare the prophylactic effects of oral gabapentin, pregabalin, and celecoxib on reducing postsurgical pain of the lower extremity orthopedic surgery. MATERIALS AND METHODS: In a double-blind randomized controlled trial, 120 patients were randomly divided into four groups using block design randomization. 1 h before spinal anesthesia, the studied groups received 300 mg oral gabapentin; 75 mg oral pregabalin; 200 mg oral celecoxib; and starch as placebo. The severity of postoperative pain (using visual analog scale), mean arterial pressure, heart rate, opioid consumption dose, and drug side effects were recorded for six times (each 60 min up to two times and then every 6 h for the next four times). Chi-square, one-way analysis of variance (ANOVA), and ANOVA repeated measure tests were used for statistical analysis. RESULTS: : 0.014). Patients in the pregabalin group required lower dose of opioid compared to placebo group during admission in surgical ward. There were no significant differences concerning pain reduction, opioid administration, and side effects between pregabalin, gabapentin, and celecoxib groups. CONCLUSION: h postoperation as well as less opioid consumption and much more patients' satisfaction.

Topics & Concepts

PregabalinMedicineGabapentinAnesthesiaCelecoxibPlaceboOrthopedic surgeryRandomizationRandomized controlled trialOpioidVisual analogue scaleSurgeryInternal medicineAlternative medicineReceptorPathologyAnesthesia and Pain ManagementOpioid Use Disorder TreatmentInflammatory mediators and NSAID effects